Cargando…
Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
Plant-based biomanufacturing of therapeutic proteins is a relatively new platform with a small number of commercial-scale facilities, but offers advantages of linear scalability, reduced upstream complexity, reduced time to market, and potentially lower capital and operating costs. In this study we...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098453/ https://www.ncbi.nlm.nih.gov/pubmed/27559626 http://dx.doi.org/10.1080/19420862.2016.1227901 |